How does a researcher select the right tool for a spatial biology project? The decision often centers on the core methodologies available: sequencing-based approaches and imaging-based techniques. At STOmics, our work with Stereo-seq analysis provides a distinct pathway in spatial transcriptomics technology. This article details a comparison, focusing on how our foundational method differs from traditional imaging-based spatial methods.

Defining the Core Technological Approaches

The fundamental difference lies in how each method captures data. Imaging-based spatial methods typically rely on optical imaging of predefined probes or tags bound to targets within a tissue sample. In contrast, our spatial transcriptomics technology at STOmics, named Stereo-seq, takes a sequencing-first approach. The Stereo-seq process facilitates the in situ capture of RNA information directly from a tissue section on a specialized chip, using spatial coordination barcoding. This means we gather a broad, untargeted set of transcriptomic data with precise spatial coordinates attached, which is then decoded through sequencing. This difference in data acquisition between Stereo seq analysis and imaging-based methods fundamentally shapes the scope and depth of the resulting information.

The Interplay of Resolution and Field of View

A primary consideration is the balance between resolution and the area of tissue analyzed. Many imaging-based methods can achieve high optical resolution, sometimes down to the subcellular level, but this can come at the cost of a limited field of view, making large tissue sections challenging to analyze comprehensively. Our Stereo-seq analysis is designed to address this trade-off. The proprietary Stereo-seq technology delivers both an unprecedented field of view and subcellular resolution. This capability allows for a simultaneous transcriptome study across an entire tissue section—from the macroscopic layout down to molecular details—without sacrificing one aspect for the other, a significant point of distinction in modern spatial transcriptomics technology.

From Raw Data to Biological Insight

The journey from raw data to biological understanding also diverges. Imaging-based outputs are often directly visual, which can be intuitive. The output from Stereo-seq analysis, however, is digital sequencing data paired with precise spatial locational data. This requires robust bioinformatics, for which STOmics provides solutions like SAW and StereoMap, to reconstruct spatial gene expression profiles. This digital framework enables the creation of rich, quantifiable datasets that expedite the establishment of research frameworks for studying the interplay between gene expression, cell morphology, and cellular microenvironments. The analytical depth possible with this form of spatial transcriptomics technology supports a highly quantitative and discovery-oriented research model.

Choosing between these paths depends on the specific questions of a project. Imaging-based spatial methods offer strong, targeted visualization. The Stereo-seq analysis pathway from STOmics provides a large-scale, discovery-driven approach to spatial transcriptomics technology, delivering comprehensive transcriptome-wide data across vast tissue landscapes with fine detail. For researchers looking to map complex biological systems without predefined targets, the tools and analysis provided by STOmics present a substantial and differentiated option.